Year : 2013 | Volume
| Issue : 2 | Page : 118-121
Analgesic efficacy of peritubal infiltration of ropivacaine versus ropivacaine and morphine in percutaneous nephrolithotomy under ultrasonic guidance
Geeta P Parikh, Veena R Shah, Kalpana S Vora, Manisha P Modi, Tanu Mehta, Sumedha Sonde
Department of Anaesthesia and Critical Care, Smt. K. M. Mehta and Smt. G. R. Doshi Institute of Kidney Diseases and Research Center, Dr. H. L. Trivedi Institute of Transplantation Sciences, Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India
Geeta P Parikh
28/Yogashram Society, Near Shyamal Char Rasta, Ahmedabad, Gujarat
Source of Support: None, Conflict of Interest: None
|Date of Web Publication||26-Jun-2013|
Background and Purpose: Percutaneous nephrolithotomy is a safe and effective endourologic procedure which is less morbid than open surgery. However, pain around a nephrostomy tube requires good post-operative analgesia. We hypothesize that infiltration of local anesthetic with opioid from the renal capsule to the skin around the nephrostomy tract under ultrasonic guidance would alleviate the postoperative pain for a long period. Methods: A total of 60 ASA physical status I to II patients were selected for a prospective randomized double-blind controlled study in percutaneous nephrolithotomy surgeries. Patients were divided into group R (n=30) and group RM (n=30). Balanced general anesthesia was given. After completion of the surgical procedure, a 23-gauze spinal needle was inserted at 6 and 12 O'clock position under ultrasonic guidance up to renal capsule along the nephrostomy tube. A 10 ml drug solution was infiltrated in each tract while withdrawing from renal capsule to the skin. After extubation, the patient was shifted to the post-anesthesia care unit for 24 hours. Post-operative pain was assessed using the visual analog scale (VAS) and dynamic visual analog scale (DVAS) (during deep breathing and coughing) rating 0-10 for initial 24 hours. Rescue analgesia was given in the form of injection tramadol 1.0 mg/kg intravenously when VAS ≥4 and maximum up to 400 mg in 24 hours. Time to 1 st rescue analgesic, number of doses of tramadol and total consumption of tramadol required in initial 24 hours were noted. Patients were observed for any side effect and treated accordingly. Results: Time to 1 st rescue analgesic, i.e., duration of analgesia in group RM is more prolonged than group R (P=0.0004). The number of doses of tramadol in 24 hours in group R were higher as compared to group RM (P=0.0003). The total amount of tramadol in 24 hours in group R was more than in group RM (P=0.0013). Side effects like nausea and vomiting and sedation were comparable in both the groups. Conclusion: Addition of morphine to ropivacaine for nephrostomy tract infiltration significantly prolonged the duration of post-operative analgesia and reduced the number of doses and total consumption of rescue analgesic in initial 24 hours in percutaneous nephrolithotomy surgery.
Keywords: Morphine, percutaneous nephrolithotomy, ropivacaine, ultrasound
|How to cite this article:|
Parikh GP, Shah VR, Vora KS, Modi MP, Mehta T, Sonde S. Analgesic efficacy of peritubal infiltration of ropivacaine versus ropivacaine and morphine in percutaneous nephrolithotomy under ultrasonic guidance. Saudi J Anaesth 2013;7:118-21
|How to cite this URL:|
Parikh GP, Shah VR, Vora KS, Modi MP, Mehta T, Sonde S. Analgesic efficacy of peritubal infiltration of ropivacaine versus ropivacaine and morphine in percutaneous nephrolithotomy under ultrasonic guidance. Saudi J Anaesth [serial online] 2013 [cited 2019 May 19];7:118-21. Available from: http://www.saudija.org/text.asp?2013/7/2/118/114046
| Introduction|| |
Percutaneous nephrolithotomy (PCNL) is a minimally invasive procedure. Pain around the nephrostomy tube can be distressing. Skin infiltration of local anesthetic at surgical site is not so effective. So we hypothesize that infiltration of local anesthetic alone or associated with opioid from the renal capsule to the skin along the nephrostomy tract would alleviate the postoperative pain for a long period. Blockade of opioid receptors with peripherally administered opioid is believed to result in analgesia. The aim of this study was to evaluate the hypothesis that combination of local anesthetic and opioid when injected in inflamed tissue can improve the quality of analgesia. ,
| Methods|| |
A prospective randomized double-blind controlled study was conducted in 60 ASA physical status I to II adult patients scheduled for PCNL surgery after ethical committee's approval and informed consent were obtained. We selected patients with renal stone size less than 3.0 cm with a single nephrostomy tube (22 F). Patients having supracostal puncture, excessive bleeding, and more than one puncture were excluded from the study. In all patients, balanced general anesthesia was administered using intravenous 2 μg/kg fentanyl as a premedication with vital monitoring. PCNL surgery was performed in the prone position. Patients were randomly assigned to either of the two groups R and RM (n=30 patients each) by the closed envelope method. After insertion of the nephrostomy tube, a 23-gauze 90 mm spinal needle was inserted up to renal capsule under ultrasonographic guidance along the nephrostomy tube at 6'O clock and 12'O clock position. In group R, 20 ml of 0.25% ropivacaine plus 0.5 ml distilled water and in group RM, 20 ml of 0.25% ropivacaine plus 0.5 ml of morphine (5.0 mg) were infiltrated (10 ml in each tract) while gradually withdrawing the needle and infiltrating the renal capsule, perinephric fat, muscles, subcutaneous tissue, and skin. The patient was extubated and kept in the post-anesthesia care unit under observation for 24 hours. Post-operative pain was assessed by a blind investigator using a 0-10 point visual analog scale (VAS) at rest and dynamic visual analog scale (DVAS) on deep breathing and coughing where 0 means no pain and 10 means unbearable pain. Pain score was assessed immediately after extubation, half hourly for 2 hours, every two hourly for 6 hours, and every four hourly till 24 hours. When VAS ≥4, intravenous tramadol 1 mg/kg was given as rescue analgesia and the patient was reassessed. Maximum 400 mg of tramadol was given in initial 24 hours. Both groups were compared for duration of analgesia, i.e., time to 1 st rescue analgesia, number of doses, and total consumption of tramadol in initial 24 hours. Signs of opioid side effects like drowsiness, nausea, vomiting, and pruritus were noted. Nausea was scored as 0-3 means none to severe. Sedation was scored as 0-3 means fully awake and alert to deep sleep. Injection naloxone was kept ready in case of severe variety of side effects. Post-operatively, all patients had urinary catheter for 24 hours so we could not assess urinary retention.
Statistical analysis was performed using statistical package of social sciences, i.e., SPSS version 12. Continuous data are described as mean±SD (standard deviation) and categorical variables are given as no. Continuous variables were compared using the t-test for two independent samples. Percentages were compared using Chi-square analysis. A P<0.05 was considered to be statistically significant.
| Results|| |
Sixty patients scheduled for PCNL were enrolled in the study. There were no dropouts or exclusions in the study. The demographic data regarding age, sex, weight, and duration of surgery were comparable and non-significant [Table 1]. VAS at rest and DVAS (during coughing and deep breathing) were significantly lower in the ropivacaine and morphine group [Figure 1] and [Figure 2]. The mean time for the first demand of analgesia in the RM group was at 13.7 hours and 10.7 hours in the R group (P=0.0004) [Table 2]. The mean total consumption of tramadol in the RM group was average 91 mg, while in the ropivacaine group, it was 123.2 mg, which is significantly less (P=0.0013) [Table 2]. The mean number of analgesic demands required during initial 24 hours was 1.64 in the RM group and 2.25 in the ropivacaine group (P=0.0003)) [Table 2]. The side effects like nausea and vomiting were also less in the ropivacaine group than in the RM group but they were not significant. (P>0.05) [Table 3].
| Discussion|| |
PCNL is one of the most common endourological procedures at our center. Systemic analgesics like NSAIDS and narcotics have been used for post-operative pain relief but they have their own side effects and limitations especially in patients with potential renal complications.  Local anesthetic infiltration can inhibit inflammatory and local sensitizing responses by directly suppressing some phases of inflammation. Numerous studies have described the efficacy of local anesthetic infiltration in surgical incisions.
From the study by Haleblian et al.,  it was hypothesized that the cause of pain after PCNL surgery involving the nephrostomy tube could result from structures beyond the skin puncture site like the renal capsule.
Dalela et al.  performed PCNL in 11 patients under a renal capsular block by infiltrating the nephrostomy tract and renal capsule with 2% lignocaine. He emphasized that most of the pain during PCNL is felt at the time of dilatation of renal capsule and parenchyma as it is richly innervated by pain conducting neurons. Araventinos et al.  studied the feasibility of doing PCNL in two stages in 24 patients. In the 1 st stage, the nephrostomy tube was placed after infiltrating tract site with 2% lignocaine along the direction of the intended nephrostomy tract. In the 2 nd stage, stones were removed after a week under assisted local anesthesia with 2% lignocaine suggesting that all structures especially renal capsule including perinephric fat, muscles, subcutaneous tissues, and skin contribute to the pain and infiltration of these structures by a local anesthetic drug blocks the pain impulses as was seen in our study.
Jonnavithula et al.  did the infiltration to the nephrostomy tract in 40 PCNL patients with 0.25% bupivacaine and found lesser pain scores and analgesic requirement in the bupivacaine group than the control group. In our previous study,  we have found out similar results with 0.25% bupivacaine. Gotkten et al.  used levobupivacaine infiltration to the nephrostomy tract in combination with intravenous paracetamol for post-operative analgesia and found less requirement of opioid as compared to other groups. Ugras et al.  did instillation of skin, nephrostomy tract, and renal puncture site with ropivacaine in 34 PCNL patients. They observed that the VAS at 6 hours, time to 1 st analgesic demand, and total analgesic need were significantly lower (P=0.001, 0.008, and 0.001 respectively) in the ropivacaine group than the control group.
In our study, for nephrostomy tract infiltration, we used ropivacaine as a local anesthetic and morphine as an opioid along with ropivacaine as it is pure μ receptor agonist with great analgesic potency and long half life. Opioids exert their analgesic effect by acting exclusively in the central nervous system (CNS). However, evidence reveals a peripheral opioid action on receptors without central action raising the possibility of divorcing analgesic action from unwanted central side effects. Many studies on analgesic efficacy of peripheral opioids have been published but the results are conflicting and various mechanisms are proposed for activation of opioid receptors on peripheral neurons.
Mehta et al.  performed incisional infiltration of bupivacaine versus bupivacaine with buprenorphine in 40 open donor nephrectomy patients. They concluded that addition of buprenorphine to local anesthetic significantly prolonged the time to 1 st rescue analgesic demand and total consumption of rescue analgesic in 24 hours thus providing evidence in support of the existence of peripheral opioid receptors.
Opioids are associated with some side effects particularly with systemic administration like respiratory depression, nausea and vomiting, itching, and urinary retention. In our study, none of the patient had respiratory depression or itching. The side effects like nausea and vomiting and sedation were comparable and mild in both groups. All patients had post-operative urinary catheter so urinary retention was not observed.
| Conclusion|| |
Addition of morphine to the local anesthetic, ropivacaine for nephrostomy tract infiltration significantly prolonged the duration of post-operative analgesia and reduced the number of doses and total consumption of rescue analgesic in initial 24 hours in percutaneous nephrolithotomy surgery which favors the existence of peripheral opioid receptors.
| References|| |
|1.||Rittner HL, Brack A, Stein C. Pain and the inflamed system. Br J Anaesth 2008;101:40-4. |
|2.||Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-90. |
|3.||Schlondorff D. Renal complications of non steroidal anti-inflammatory drugs. Kidney Int 1993;44:643-53. |
|4.||Haleblian GE, Sur RL, Albala DM, Preminger GM. Subcutaneous bupivacaine infiltration and postoperative pain perception after percutaneous nephrolithotomy. J Urol 2007;178:925-8. |
|5.||Dalela D, Goel A, Singh P, Shankhwar S. Renal capsular block: A novel method performing percutaneous nephrolithotomy under local anaesthesia. J Endourol 2004;18:544-6. |
|6.||Aravanitos E, Karatzas A, Gravas S, Tzortzis V, Melekos M. Feasibility of percutaneous nephrolithotomy under assisted local anaesthesia: A prospective study on selected patients with upper urinary tract obstruction. EurUrol 2007;51:224-7. |
|7.||Jonnavithula N, Pisapati MV, Durga P, Krishnamurthy V, Chilumu R, Reddy B. Efficacy of peritubal local anesthetic infiltration in alleviating postoperative pain in percutaneous nephrolithotomy. J Endourol 2009;23:857-60. |
|8.||Parikh GP, Shah VR, Modi MP, Chauhan NC. The analgesic efficacy of peritubal infiltration of 0.25% bupivacaine in percutaneous nephrolithotomy-A prospective randomized study. J Anaesthesiol Clin Pharmacol 2011;27:481-4. |
|9.||Gokten OE, Kilicarslan H, Dogan HS, Turker G, Kordan Y. Efficacy of levobupivacaine infiltration to nephrosthomy tract in combination with intravenous paracetamol on postoperative analgesia in percutaneous nephrolithotomy patients. J Endourol 2011;25:35-9. |
|10.||Ugras MY, Toprak HI, Gunen H, Yucel A, Gunes A. Instillation of skin, nephrostomy tract, and renal puncture site with ropivacaine decreases pain and improves ventilatory function after percutaneous nephrolithotomy. J Endourol 2007;21:499-503. |
|11.||Mehta TR, Parikh BK, Bhosale GP, Butala BP, Shah VR. Post operative analgesia after incisional infiltration of bupivacaine v/s bupivacaine with buprenorphine. J Anaesthesiol Clin Pharmacol 2011;27:211-4. |
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Endogenous opiates and behavior: 2014
| ||Richard J. Bodnar |
| ||Peptides. 2016; 75: 18 |
|[Pubmed] | [DOI]|
||Effects of Ropivacaine on Postoperative Pain and Peak Expiratory Flow Rate in Patients Undergoing Percutaneous Nephrolithotomy
| ||Farsad Imani,Somayyeh Zamani,Farhad Etezadi,Reza Shariat Moharari,Mohammad Reza Khajavi,Seyed Reza Hosseini |
| ||Nephro-Urology Monthly. 2015; 7(6) |
|[Pubmed] | [DOI]|